Diabetes drugs may shield against severe pneumonia outcomes
NCT ID NCT07708610
First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time
Summary
This study looks at whether taking a combination of GLP-1 receptor agonists and SGLT2 inhibitors before being hospitalized with pneumonia improves early outcomes in adults with type 2 diabetes. Researchers analyzed health records from over 70,000 patients, comparing those on both drugs to those on one or neither. The goal is to see if these medications reduce the risk of death, need for a breathing machine, or kidney replacement therapy within 30 days.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- GLP-1 receptor agonists and SGLT2 inhibitors (glucose-lowering drugs)
- What this could lead to
- If these drugs improve pneumonia outcomes, it could point to better treatment strategies for people with type 2 diabetes hospitalized with pneumonia.
- What could go wrong
- This is an observational study, not a controlled trial, so results may be influenced by other factors. The findings need confirmation in prospective studies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMONIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chung Shan Medical University Hospital
Taichung, Taichung, 402, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Student pharmacists may hold the key to better diabetes control in older asian adults
- Can a blood vessel drug beat aspirin at preventing heart attacks in diabetes?
- New Dual-Action drug aims to tackle fatty liver where semaglutide falls short
- Can a 12-Week exercise program boost brain and body health in older adults with diabetes?
- Home hospital care for infections: when does it fail?
- Saliva test could spot hidden links between diabetes and gum disease